Drug intelligence / Profile preview

siSETD5

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Injection
01

Overview

siSETD5 is a small interfering RNA (siRNA) designed to silence the expression of the SETD5 (SET Domain Containing 5) gene. SETD5 is a histone lysine methyltransferase that plays a significant role in epigenetic regulation and has been implicated in the progression of various cancers, particularly hepatocellular carcinoma (HCC). By targeting SETD5 mRNA for degradation, siSETD5 reduces SETD5 protein levels, which in turn suppresses tumor cell proliferation and invasion, induces apoptosis, and downregulates the interferon-mediated inflammatory response and glycolytic activity (specifically by reducing PKM expression). Research indicates that siSETD5 can inhibit tumor growth in preclinical xenograft models, suggesting its potential as a therapeutic strategy for HCC.

Other names
SETD5 siRNASETD-5 siRNASETD 5 siRNAsmall interfering RNA targeting SETD5
02

Targets

KMT (Histone-lysine methyltransferases)

Beyond the preview

Go deeper on siSETD5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siSETD5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call